Crossmark

Low-exhaustion peripheral circulating γδ T cells serve as a biomarker for predicting the clinical benefit rate of non-small cell lung cancer (NSCLC) patients to chemotherapy or targeted therapy: a single-center retrospective study

Crossref DOI link: https://doi.org/10.1186/s12885-025-13497-2

Published Online: 2025-01-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Dongdong

Liu, Guichao

Ye, Jinhui

Li, Ke

Zhang, Guojun

Quan, Qiang

Zhu, Xinhai

Li, Peng
Funding

Funding for this research was provided by:

Shenzhen Science and Technology Program (JCYJ20240813150420027)

National Natural Science Foundation of China (32300728)

Guangdong Basic and Applied Basic Research Foundation (2022A1515110416)

China Postdoctoral Science Foundation (2022M713670)
License Information

Text and Data Mining valid from 2025-01-30

Version of Record valid from 2025-01-30
More Information

Article History

Received: 10 October 2024

Accepted: 12 January 2025

First Online: 30 January 2025

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Research Ethics Committee of the First Affiliated Hospital, Jinan University, Guangzhou, China and the need of informed consent for this study was exempted in the ethical approval documents (approval numbers KY-2020-10 and KY-2020-11).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below